Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

NCT02396862 ·Status: COMPLETED

BAY14-2222 Continuous Infusion in Surgeries

NCT00606060 ·Status: COMPLETED ·Phase: PHASE3

Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery

NCT00922597 ·Status: COMPLETED

Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A

NCT02930317 ·Status: UNKNOWN ·Phase: PHASE3

Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

NCT02634723 ·Status: COMPLETED

Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China

NCT02336178 ·Status: COMPLETED ·Phase: PHASE4

Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."

NCT02581969 ·Status: COMPLETED

Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

NCT00782470 ·Status: COMPLETED

Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients

NCT01817868 ·Status: COMPLETED

Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A

NCT00621673 ·Status: TERMINATED ·Phase: PHASE4

Lentiviral FVIII Gene Therapy

NCT03217032 ·Status: RECRUITING ·Phase: PHASE1

The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.

NCT05630651 ·Status: RECRUITING ·Phase: NA

A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

NCT05147662 ·Status: COMPLETED ·Phase: PHASE3

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

NCT00623480 ·Status: COMPLETED ·Phase: PHASE3

PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A

NCT02492984 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.

NCT05523128 ·Status: RECRUITING ·Phase: NA

China ADVATE PTP Study

NCT02170402 ·Status: COMPLETED ·Phase: PHASE4

EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan

NCT00932555 ·Status: COMPLETED

Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old

NCT05709288 ·Status: RECRUITING ·Phase: PHASE1

Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in China

NCT03598725 ·Status: UNKNOWN ·Phase: PHASE4

Lentiviral FIX Gene Therapy

NCT03961243 ·Status: RECRUITING ·Phase: PHASE1

Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A

NCT01029340 ·Status: COMPLETED ·Phase: PHASE3

Outcomes of Prophylaxis and On-demand Treatment for Severe Hemophiliacs and Collection of Baseline Data in Hemophiliacs in Taiwan

NCT02908243 ·Status: UNKNOWN

Pharmacokinetic (PK)Research on Chinese Children of Hemophilia

NCT03622476 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A

NCT02280265 ·Status: UNKNOWN ·Phase: NA